Akesobio, China – Integrated automation to drive the industrialization
of mAb production
Large Scale DCS System
Breakthrough Reference @ Bio Pharma
Akesobio, China – Integrated automation to drive the industrialization
of mAb production
Pharmaceuticals
Zhongshan Akesobio Medicine Co. Ltd
Guangdong Province Zhongshan City China
Akeso, Inc. (9926.HK) is a biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of new innovative antibody drugs that are affordable to patients worldwide. It is one of the Top 6 Bio Pharma companies in
China.
Project Position: Upon
completion it will be the No. 2 pipeline in the market with a total capacity of
40,000 liters via 4x10,000 L stainless Bio reactors. Project Scope: It
covers the total integrated automation and Batch system incl. upstream,
downstream and auxiliary (upstream bioreactor system, downstream
ultrafiltration system and chromatography system, auxiliary CIP/SIP stations,
etc.).
PCS
7 V9.1 + Batch + AS410H + ET 200SP HA + SCALANCE
+ SITOP
2
x OS Server + 2 x Batch Server + 42 x Client + 4 pairs of Controllers (≈5200
IO)
Valve
island + Virtualization + Disaster tolerance system + MCC variable frequency
cabinet
Installation
and engineering services.
The
professionality, passion and team work of SIEMENS, are the key factors which move Akesobio.
Dr. Xia Yu, Senior Vice Precident of Akesobio
Excellent
branch knowhow and project control experience (process control, integration and
interaction) to facilitate better project implementation.
Unified
automation system platform to simplify the operation and maintenance
Flexible
batch integration to realize the receipt driving production process.
Fully
integrated Ethernet architecture with flexible network topology and
communication redundancy.
Zhongshan
Cuiheng New District Akesobio Bay Science park
.png&w=3840&q=75)